Heralded Alzheimer's Drug Works, but Safety Concerns Loom
Eisai and Biogen share clinical trial data confirming that lecanemab slows mental decline amid reports of potentially related deaths
Source: scientificamerican.com
Stay updated with breaking news from Rob Howard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eisai and Biogen share clinical trial data confirming that lecanemab slows mental decline amid reports of potentially related deaths
Doctors have hailed a new era of medicine after a study showed for the first time that a drug can slow the debilitating symptoms of Alzheimer's.
Results of a phase three Alzheimer's drug trial appeared to slow progression of the disease. But how effective is lecanemab really?
It may just be a first step, but Lecanemab is fuelling hope that we're getting closer to a cure.
New Alzheimer’s drug slows memory loss